Nanopore Sequencing Market Size, Scope, Forecast Report 2026 to 2035
What is Nanopore Sequencing Market Size?
Global Nanopore Sequencing Market Size was valued at USD 380.95 Mn in 2025 and is predicted to reach USD 1,169.93 Mn by 2035 at a 12.0% CAGR during the forecast period for 2026 to 2035.
Nanopore Sequencing Market Size, Share & Trends Analysis Report, By Product (Instruments, Consumables), By Type of Nanopore (Solid State, Biological, Hybrid), By Type of Nucleotide Sequenced (DNA, RNA), By Application, By End-user, By Region, Forecasts, 2026 to 2035.
Nanopore Sequencing Market Key Takeaways:
|
Nanopore sequencing is a novel, scalable method that enables direct, real-time examination of lengthy DNA or RNA fragments. The technique operates by tracking how an electrical current changes when nucleic acids move through a protein nanopore. The resultant signal is often decoded to provide a particular sequence of DNA or RNA. The growing prevalence of genetic disorders, increasing demand for personalised medicine, and advancements in sequencing technology are the primary factors driving the market's rapid growth.
The market is growing, in large part, due to the potential uses of nanopore sequencing in various industries and its ability to deliver real-time data. Furthermore, the growth of biotechnology and pharmaceutical firms, population growth, improved healthcare facilities, and increasing public awareness of genetic illnesses all have a favourable impact on the nanopore sequencing industry.
Additionally, during the projection period, market participants would have more profitable opportunities due to the adoption of improved genetic treatments. However, worries about mistake rates are anticipated to hinder market expansion. During the forecast period, the nanopore sequencing market is expected to face challenges due to a shortage of skilled personnel.
Competitive Landscape
Some of the Major Key Players in the Nanopore Sequencing Market are:
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Pacific Biosciences
- Oxford Nanopore Technologies Limited
- QIAGEN
- F. Hoffmann-La Roche Ltd.
- PerkinElmer Inc.
- Thermo Fisher Scientific
- Eurofins Scientific
- Agilent Technologies, Inc.
- Myriad Genetics, Inc.
- Others
Market Segmentation:
The nanopore sequencing market is segmented based on product, type of nucleotide sequenced, type of nanopore, application, and end-user. Based on product, the market is segmented into instruments and consumables. By type of nucleotide sequenced, the market is segmented into DNA and RNA. By type of nanopore, the market is segmented into solid state, biological, and hybrid. By application, the market is segmented into clinical research, human genetics, animal research, and others. By end-user, the market is segmented into clinical laboratories, biotechnological companies, academic & research institutes, and others.
Based on the Product, the Consumables Segment is Accounted as a Major Contributor to the Nanopore Sequencing Market
The consumables segment is expected to hold a major global market share in 2024. The strong demand for kits and reagents is a primary driver of the dominance of consumables in the nanopore sequencing market. The increase in consumable usage is evident in various processes, including RNA and DNA sequencing. Additionally, these consumables are being used in hitherto undiscovered applications, which broadens their use and increases demand for them. The demand for dependable and effective consumables has increased in tandem with the development of nanopore sequencing technology. To ensure accurate and precise results in their genetic studies, scientists and researchers rely on these consumables.
Diagnostic Laboratories Segment to Witness Growth at a Rapid Rate
The DNA segment led the nanopore sequencing market in 2024. The increasing clinical benefits of nanopore technologies in DNA sequencing, rising technological breakthroughs, and expanding strategic actions by prominent market players are the main drivers propelling the expansion of the DNA sector. Additionally, the growing clinical uses of nanopore sequencing technologies for DNA sequencing are anticipated to boost their use, which will boost the revenue of the studied segment throughout the projected period.
In the Region, the North American Nanopore Sequencing Market Holds a Significant Revenue Share
The North American nanopore sequencing market is expected to register the highest market share in revenue in the near future because of its highly developed healthcare system, substantial R&D expenditures, and the presence of important industrial players. Growing genetic problems and government support for genomics and tailored medicine drive market growth. In addition, Asia Pacific is projected to grow rapidly in the global Nanopore Sequencing market because cutting-edge genomics technologies are being used in both clinical and research settings. Collaborations and strong research institutes foster innovation and commercial expansion. In the Asia-Pacific area, nanopore sequencing is expanding quickly due to investments in biotechnology and research.
Recent Development:
- September 2024: CycloneSEQ-WT02 and CycloneSEQ-WY01, two nanopore gene sequencing products, have been commercialized and distributed worldwide by MGI Tech Co., a Chinese firm. With a number of scientific advancements, including sophisticated protein engineering, a novel flow cell architecture, and a cutting-edge base calling algorithm, the CycloneSEQ technology exhibits promise in a variety of genomics domains. It is designed to achieve high sequencing accuracy and throughput.
- August 2024: Oxford Nanopore Technologies received an investment of GBP 50 million (USD 63 million) from Novo Holding. Through real-time workflows, Oxford Nanopore's analytical technology is being utilized for DNA and RNA sequencing, giving users insights into the epigenetics of a material. This investment demonstrated Oxford Nanopore's expanding potential in the biopharmaceutical industry and the company's faith in its technology.
Nanopore Sequencing Market Report Scope :
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 380.95 Mn |
| Revenue Forecast In 2035 | USD 1,169.93 Mn |
| Growth Rate CAGR | CAGR of 12.0% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Type Of Nucleotide Sequenced, By Type Of Nanopore, By Application, End-User. and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | Bio-Rad Laboratories, Inc., Danaher Corporation, Pacific Biosciences, Oxford Nanopore Technologies Limited, QIAGEN, F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Thermo Fisher Scientific, Eurofins Scientific, Agilent Technologies, Inc., Myriad Genetics, Inc., and other prominent players. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Nanopore Sequencing Market-
Nanopore Sequencing Market- By Product
- Instruments
- Consumables
Nanopore Sequencing Market- By Type of Nucleotide Sequenced
- DNA
- RNA
Nanopore Sequencing Market- By Type of Nanopore
- Solid State
- Biological
- Hybrid
Nanopore Sequencing Market- By Application
- Clinical Research
- Human Genetics
- Animal Research
- Others
Nanopore Sequencing Market- By End-User
- Clinical Laboratories
- Biotechnological Companies
- Academic & Research Institutes
- Others
Nanopore Sequencing Market- By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Nanopore Sequencing Market Size was valued at USD 380.95 Mn in 2025 and is predicted to reach USD 1,169.93 Mn by 2035.
Nanopore Sequencing Market is expected to grow at a 12.0% CAGR during the forecast period for 2026-2035.
Bio-Rad Laboratories, Inc., Danaher Corporation, Pacific Biosciences, Oxford Nanopore Technologies Limited, QIAGEN, F. Hoffmann-La Roche Ltd., PerkinE
nanopore sequencing market is segmented based on product, type of nucleotide sequenced, type of nanopore, application, and end-user, solid state, biological, and hybrid.
North America region is leading the Nanopore Sequencing Market.